Intestinal microbiome changes and mechanisms of maintenance hemodialysis patients with constipation
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 2
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Treatment outcome measurement Treatment outcome measurement,treatment outcome measurement
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy Control Group (HCG)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Maintenance Hemodialysis with Constipation (MHDCG)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients undergoing hemodialysis also experiencing constipation.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 15
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 1 Month
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Figure 5 and 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: increased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
NCBI | Quality Control | Links |
---|---|---|
Akkermansia | ||
Altererythrobacter | ||
Dubosiella | ||
Eggerthella | ||
Enterococcus | ||
Filomicrobium | ||
Herminiimonas | ||
Ruegeria | ||
Verrucomicrobiota | ||
Prevotella_7Prevotella_7 | ||
Clostridium sp. CAG:352 |
Revision editor(s): Shulamite
Signature 2
Source: Figure 5 and 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: decreased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
Revision editor(s): Shulamite
Experiment 3
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Maintenance Hemodialysis without Constipation (MHDNCG)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Hemodialysis patients who do not experience constipation.
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- decreased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- decreased
- Richness Number of species
- decreased
Signature 1
Source: Figure 5 and 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: increased abundance in Maintenance Hemodialysis without Constipation (MHDNCG)
NCBI | Quality Control | Links |
---|---|---|
Akkermansia | ||
Clostridium sp. CAG:352 | ||
Neisseria | ||
unclassified Lachnospiraceae | ||
Verrucomicrobiota |
Revision editor(s): Shulamite
Signature 2
Source: Figure 5 and 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: decreased abundance in Maintenance Hemodialysis without Constipation (MHDNCG)
Revision editor(s): Shulamite
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Maintenance Hemodialysis without Constipation (MHDNCG)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Maintenance Hemodialysis with Constipation (MHDCG)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients undergoing hemodialysis also experiencing constipation.
Lab analysis
Statistical Analysis
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- increased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- decreased
- Richness Number of species
- increased
Signature 1
Source: Figure 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: increased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
NCBI | Quality Control | Links |
---|---|---|
Allobaculum | ||
Eggerthella | ||
Enterococcus | ||
Filomicrobium | ||
Gordonibacter | ||
Lachnoanaerobaculum | ||
unclassified Hyphomicrobiales | ||
Prevotella_7Prevotella_7 |
Revision editor(s): Shulamite
Signature 2
Source: Figure 6
Description: Comparison of species abundance at the genus level.
Abundance in Group 1: decreased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
NCBI | Quality Control | Links |
---|---|---|
Kineothrix | ||
Rhodopirellula | ||
Weissella |
Revision editor(s): Shulamite
Experiment 5
Subjects
Lab analysis
Statistical Analysis
- Statistical test
- LEfSe
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Alpha Diversity
- Pielou Quantifies how equal the community is numerically
- decreased
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
- Chao1 Abundance-based estimator of species richness
- increased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- decreased
- Richness Number of species
- increased
Signature 1
Source: Figure 7
Description: LEfSe analysis. The abundance difference analysis plots for the MHDCG and MHDNCG groups at the genus level.
Abundance in Group 1: decreased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
NCBI | Quality Control | Links |
---|---|---|
Phocaeicola coprocola | ||
Rhodopirellula | ||
Veillonellaceae | ||
Weissella | ||
unclassified Rhodopirellula | ||
unclassified Weissella | ||
Veillonellales_SelenomonadalesVeillonellales_Selenomonadales |
Revision editor(s): Shulamite
Signature 2
Source: Figure 7
Description: LEfSe analysis. The abundance difference analysis plots for the MHDCG and MHDNCG groups at the genus level.
Abundance in Group 1: increased abundance in Maintenance Hemodialysis with Constipation (MHDCG)
Revision editor(s): Shulamite